Follow
olivier benichou
olivier benichou
Unknown affiliation
Verified email at lilly.com
Title
Cited by
Cited by
Year
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
L Van Wesenbeeck, E Cleiren, J Gram, RK Beals, O Bénichou, ...
The American Journal of Human Genetics 72 (3), 763-771, 2003
6452003
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene
E Cleiren, O Bénichou, E Van Hul, J Gram, J Bollerslev, FR Singer, ...
Human molecular genetics 10 (25), 2861-2867, 2001
4392001
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
C Becker, SR Lord, SA Studenski, SJ Warden, RA Fielding, CP Recknor, ...
The lancet Diabetes & endocrinology 3 (12), 948-957, 2015
3612015
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients
OD Benichou, JD Laredo, MC De Vernejoul
Bone 26 (1), 87-93, 2000
2902000
A phase II randomized study of subcutaneous ixekizumab, an anti–interleukin‐17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an …
MC Genovese, M Greenwald, CS Cho, A Berman, L Jin, GS Cameron, ...
Arthritis & rheumatology 66 (7), 1693-1704, 2014
2192014
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III study (SPIRIT-P1)
D van der Heijde, DD Gladman, M Kishimoto, M Okada, SS Rathmann, ...
The Journal of rheumatology 45 (3), 367-377, 2018
1192018
Rationale for strengthening muscle to prevent falls and fractures: a review of the evidence
O Benichou, SR Lord
Calcified tissue international 98 (6), 531-545, 2016
1132016
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate
MC Genovese, E Lee, J Satterwhite, M Veenhuizen, D Disch, PY Berclaz, ...
Annals of the rheumatic diseases 72 (9), 1453-1460, 2013
1092013
Tibial coverage, meniscus position, size and damage in knees discordant for joint space narrowing–data from the Osteoarthritis Initiative
K Blöcker, A Guermazi, W Wirth, O Benichou, CK Kwoh, DJ Hunter, ...
Osteoarthritis and cartilage 21 (3), 419-427, 2013
1042013
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21
W Van Hul, J Bollerslev, J Gram, E Van Hul, W Wuyts, O Benichou, ...
The American Journal of Human Genetics 61 (2), 363-369, 1997
911997
Sensitivity to change of cartilage morphometry using coronal FLASH, sagittal DESS, and coronal MPR DESS protocols–comparative data from the Osteoarthritis Initiative (OAI)
W Wirth, M Nevitt, MPH Le Graverand, O Benichou, D Dreher, RY Davies, ...
Osteoarthritis and Cartilage 18 (4), 547-554, 2010
852010
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
MC Genovese, RM Fleischmann, M Greenwald, J Satterwhite, ...
Annals of the rheumatic diseases 72 (9), 1461-1468, 2013
842013
MRI-based extended ordered values more efficiently differentiate cartilage loss in knees with and without joint space narrowing than region-specific approaches using MRI or …
W Wirth, R Buck, M Nevitt, MPH Le Graverand, O Benichou, D Dreher, ...
Osteoarthritis and Cartilage 19 (6), 689-699, 2011
822011
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13. 3
O Bénichou, E Cleiren, J Gram, J Bollerslev, MC de Vernejoul, W Van Hul
The American Journal of Human Genetics 69 (3), 647-654, 2001
792001
Femorotibial subchondral bone area and regional cartilage thickness: A cross‐sectional description in healthy reference cases and various radiographic stages of osteoarthritis …
RB Frobell, MC Nevitt, M Hudelmaier, W Wirth, BT Wyman, O Benichou, ...
Arthritis care & research 62 (11), 1612-1623, 2010
762010
Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force
M Cesari, R Fielding, O Bénichou, R Bernabei, S Bhasin, JM Guralnik, ...
The Journal of frailty & aging 4 (3), 114, 2015
752015
Human osteopetrosis and other sclerosing disorders: recent genetic developments
MC Vernejoul, O Benichou
Calcified Tissue International 69 (1), 1, 2001
722001
A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty.
L Woodhouse, R Gandhi, SJ Warden, S Poiraudeau, SL Myers, ...
The Journal of frailty & aging 5 (1), 62-70, 2016
712016
Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis?
B Cortet, O Bénichou
Joint Bone Spine 73 (5), e1-e7, 2006
712006
Rates of change and sensitivity to change in cartilage morphology in healthy knees and in knees with mild, moderate, and end‐stage radiographic osteoarthritis: Results from 831 …
F Eckstein, M Nevitt, A Gimona, K Picha, JH Lee, RY Davies, D Dreher, ...
Arthritis care & research 63 (3), 311-319, 2011
702011
The system can't perform the operation now. Try again later.
Articles 1–20